About Matthias

A molecular biochemist and bioinformatician by training, Matthias co-leads our work in R&D and Medical functions globally. He has led projects in Europe, the United States, India, and China, supporting pharmaceutical and medical products companies as they take on strategic challenges around innovation, driving R&D productivity, pipeline value creation, and succeeding in access and early commercialization.

Matthias has served clients on innovation strategies, holistic R&D performance transformations, clinical product strategies, and functional-excellence and capability building initiatives in areas including translational medicine, medical affairs, and regulatory affairs. In his recent work, he has helped identify new ways of working in an industry-leading development organization to accelerate pipeline progress and make better use of available funds. He also helped to build medical-affairs organizations to provide deep medical insights to ensure safe and appropriate use of important pipeline compounds. Matthias is one of the co-founders of McKinsey’s cross-industry Medical Affairs Forum.

Passionate about science innovation to better serve patients, Matthias pursues several cross-industry activities to fuel innovation and create more science leadership capacity. He is a frequent speaker at high-profile events such as the Lindau Nobel Laureate Meeting and Biotech Revolutions GAP Summit, which support young researchers and academia.

Published work

How pharma manufacturers can enhance their medical information teams,” McKinsey & Company, May 2018

Real-world evidence: From activity to impact in healthcare decision making,” McKinsey & Company, May 2018

Medical affairs: Key imperatives for engaging and educating physicians in a digital world,” McKinsey & Company, March 2018

From Science to Operations: Questions, Choices and Strategies for Success in Biopharma,” McKinsey & Company, March 2014, p. 99-102

Escaping the sword of Damocles: Toward a new future for pharmaceutical R&D,” (PDF–1.7 MB), McKinsey & Company, 2012

Value-driven drug development—Unlocking the value of your pipeline,” (PDF–293 KB), McKinsey & Company, 2011

The future of drug development: Advancing clinical trial design,” Nature Reviews Drug Discovery, December 2009

Past experience

German Biotech
Associate scientist/fellow


Ruhr University Bochum, Germany and Center for Molecular Neurobiology, Hamburg
PhD, biochemistry with a focus on neuroscience